Stocks and Investing
Stocks and Investing
Mon, November 14, 2022
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
[ Mon, Nov 14th 2022
] - WOPRAI
Ann Hynes Maintained (CAH) at Hold with Increased Target to $74 on, Nov 14th, 2022
Ann Hynes of Mizuho, Maintained "Cardinal Health, Inc." (CAH) at Hold with Increased Target from $66 to $74 on, Nov 14th, 2022.
Ann has made no other calls on CAH in the last 4 months.
There are 7 other peers that have a rating on CAH. Out of the 7 peers that are also analyzing CAH, 4 agree with Ann's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Eric Coldwell of "Baird" Maintained at Hold with Increased Target to $82 on, Monday, November 7th, 2022
- Michael Cherny of "B of A Securities" Upgraded from Sell to Hold and Increased Target to $80 on, Friday, November 4th, 2022
- Charles Ryhee of "Cowen & Co." Maintained at Hold with Increased Target to $72 on, Tuesday, August 16th, 2022
- A.J. Rice of "Credit Suisse" Maintained at Hold with Increased Target to $64 on, Friday, August 12th, 2022
These are the ratings of the 3 analyists that currently disagree with Ann
- Erin Wright of "Morgan Stanley" Maintained at Buy with Increased Target to $82 on, Monday, November 7th, 2022
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Increased Target to $78 on, Monday, August 29th, 2022
- Ricky Goldwasser of "Morgan Stanley" Maintained at Buy with Decreased Target to $70 on, Thursday, July 14th, 2022
Contributing Sources